Search filters

List of works by Stefan Düsterhöft

A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptor

scientific article (publication date: 6 June 2014)

ADAM17-triggered TNF signalling protects the ageing Drosophila retina from lipid droplet-mediated degeneration

scientific article published on 26 July 2020

Amphiregulin Regulates Phagocytosis-Induced Cell Death in Monocytes via EGFR and the Bcl-2 Protein Family

scientific article published on 03 November 2019

Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.

scientific article published on 6 May 2016

Control of ADAM17 activity by regulation of its cellular localisation

scientific article published on 12 October 2016

Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells

scientific article published on 13 December 2020

GRP78 protects a disintegrin and metalloprotease 17 against protein-disulfide isomerase A6 catalyzed inactivation

scientific article

Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation

scientific article

Rhomboid proteases in human disease: Mechanisms and future prospects.

scientific article

Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.

scientific article

Status update on iRhom and ADAM17: It's still complicated

scientific article published on 19 July 2019

The SNP rs4252548 (R112H) which is associated with reduced human height compromises the stability of IL-11.

scientific article published on 10 December 2017

The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release

scientific article published on 05 May 2021

The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II

scientific article published on 21 March 2012

The metalloprotease ADAM17 in inflammation and cancer

scientific article published on 06 April 2019